Biomarkers Predicting Recurrence and Progression of Ductal Carcinoma In Situ Treated by Lumpectomy Alone

被引：8
|
作者：
Allred, D. Craig [1 ]
机构：
[1] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA
来源：
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2010年 / 102卷 / 09期
关键词：
SURGICAL ADJUVANT BREAST; INTRADUCTAL-CARCINOMA; PATHOLOGICAL FINDINGS; PROTOCOL B-17; CANCER; TAMOXIFEN; EXPRESSION; PHENOTYPE; DCIS; B-24;
D O I：
10.1093/jnci/djq118
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：585 / 587
页数：3
相关论文
共 50 条
  • [1] miRNAs as Biomarkers for Predicting the Progression of Ductal Carcinoma in Situ
    Hannafon, Bethany N.
    Ding, Wei-Qun
    AMERICAN JOURNAL OF PATHOLOGY, 2018, 188 (03): : 542 - 549
  • [2] Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy
    Kerlikowske, K
    Molinaro, A
    Cha, I
    Ljung, BM
    Ernster, VL
    Stewart, K
    Chew, K
    Moore, DH
    Waldman, F
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (22): : 1692 - 1702
  • [3] Potential biomarkers of ductal carcinoma in situ progression
    Dettogni, Raquel Spinasse
    Stur, Elaine
    Laus, Ana Carolina
    da Costa Vieira, Rene Aloisio
    Chiquitelli Marques, Marcia Maria
    Vidigal Santana, Iara Viana
    Pulido, Jose Zago
    Ribeiro, Laura Fregonassi
    Parmanhani, Narelle de Jesus
    Agostini, Lidiane Pignaton
    dos Reis, Raquel Silva
    Wolfgramm dos Santos, Eldamaria de Vargas
    Rebello Alves, Lyvia Neves
    Garcia, Fernanda Mariano
    Santos, Jessica Aflavio
    Ventorim, Diego do Prado
    Reis, Rui Manuel
    Louro, Iuri Drumond
    BMC CANCER, 2020, 20 (01)
  • [4] Potential biomarkers of ductal carcinoma in situ progression
    Raquel Spinassé Dettogni
    Elaine Stur
    Ana Carolina Laus
    René Aloísio da Costa Vieira
    Márcia Maria Chiquitelli Marques
    Iara Viana Vidigal Santana
    José Zago Pulido
    Laura Fregonassi Ribeiro
    Narelle de Jesus Parmanhani
    Lidiane Pignaton Agostini
    Raquel Silva dos Reis
    Eldamária de Vargas Wolfgramm dos Santos
    Lyvia Neves Rebello Alves
    Fernanda Mariano Garcia
    Jéssica Aflávio Santos
    Diego do Prado Ventorim
    Rui Manuel Reis
    Iúri Drumond Louro
    BMC Cancer, 20
  • [5] Predicting local recurrence in patients treated for ductal carcinoma in situ of the breast (DCIS)
    Martinez-Perez, Carlos
    Turnbull, Arran K.
    Ekatah, Gregory E.
    Arthur, Laura M.
    Fernando, Anu
    Sims, Andrew H.
    Thomas, Jeremy S.
    Dixon, J. Michael
    CANCER RESEARCH, 2018, 78 (04)
  • [6] Ductal carcinoma in situ (DCIS) treated with excision alone: Predictors of local recurrence (LR).
    Collins, L
    Lester, S
    Cooper, A
    Hetelekidis, S
    Silver, B
    Harris, J
    Connolly, J
    Schnitt, S
    LABORATORY INVESTIGATION, 1997, 76 (01) : 80 - 80
  • [7] Role of Biomarkers (CD44, E-cadherin and β-catenin) in Predicting Recurrence and Progression of Ductal Carcinoma In Situ of the Breast
    Tan, Benjamin Yongcheng
    Ong, Clara
    Koh, Valerie
    Thike, Aye Aye
    Tan, Puay-Hoon
    LABORATORY INVESTIGATION, 2016, 96 : 75A - 75A
  • [8] Role of Biomarkers (CD44, E-cadherin and β-catenin) in Predicting Recurrence and Progression of Ductal Carcinoma In Situ of the Breast
    Tan, Benjamin Yongcheng
    Ong, Clara
    Koh, Valerie
    Thike, Aye Aye
    Tan, Puay-Hoon
    MODERN PATHOLOGY, 2016, 29 : 75A - 75A
  • [9] Utilization of lymph node assessment in patients with ductal carcinoma in situ treated with lumpectomy
    Shah, Dhruvil R.
    Canter, Robert J.
    Khatri, Vijay P.
    Bold, Richard J.
    Martinez, Steve R.
    JOURNAL OF SURGICAL RESEARCH, 2012, 177 (01) : E21 - E26
  • [10] Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy
    Giannakeas, Vasily
    Sopik, Victoria
    Narod, Steven A.
    JAMA NETWORK OPEN, 2018, 1 (04)
12345